Quality of Life after Autologous Peripheral Blood Stem

Quality of life · Autologous peripheral blood stem cell transplantation · High-risk breast cancer Summary Background: As long-term survivors of breast cancer after autologous peripheral blood stem cell transplanta-tion (ASCT) are becoming more numerous, studies ad-dressing the issue of long-term follow-up are necessary. In this study, we report on the quality of life (QOL) after ASCT and high-dose chemotherapy (HDCT). Patients and Methods: The QOL questionnaire version 3.0 by the European Organization for Research and Treatment of Cancer (EORTC QLQ-C30 version 3.0) was filled in by patients and healthy controls at 5 time points. After ob-taining the results, we analyzed the correlation between QOL and the effect factors. Results: Some functions go